Pharmaceutical composition containing cannabinoid-receptor 2 antagonists
    2.
    发明公开
    Pharmaceutical composition containing cannabinoid-receptor 2 antagonists 审中-公开
    Pharmazutische Zusammensetzung mit Cannabinoid 2-Rezeptorantagonisten

    公开(公告)号:EP2311443A1

    公开(公告)日:2011-04-20

    申请号:EP09013039.4

    申请日:2009-10-15

    摘要: The present invention relates to the use of cannabinoid-receptor 2 (CB 2 R)-antagonists for the prophylaxis and/or treatment of pathogen, in particular, parasitic protozoa, caused or induced cerebral diseases, disorders or conditions including secondary and accompanying diseases, disorders or conditions, like encephalitis. In a preferred embodiment, said CB 2 R-antagonist is a 3-pyrazole-carboxamide derivative. In a further aspect, the present invention provides pharmaceutical compositions comprising said CB 2 R-antagonist in combination with an anti-pathogenic active ingredient, optionally together with pharmaceutically acceptable carriers, diluents and/or excipients. Said pharmaceutical compositions are useful for treating encephalitis, like cerebral malaria induced by Plasmodium falciparum. Thus, in another aspect, methods for the treatment of pathogen, like parasitic protozoa induced or caused cerebral diseases, disorders or conditions including encephalitis, in particular cerebral malaria are provided comprising the steps of administering a CB 2 R-receptor antagonist.

    摘要翻译: 本发明涉及大麻素 - 受体2(CB 2 R) - 拮抗剂用于预防和/或治疗病原体,特别是寄生原虫,引起或引起的脑疾病,病症或病症,包括继发性和伴随疾病, 疾病或病症,如脑炎。 在优选的实施方案中,所述CB 2 R-拮抗剂是3-吡唑 - 甲酰胺衍生物。 在另一方面,本发明提供药物组合物,其包含所述CB 2 R-拮抗剂与抗病原活性成分,任选与药学上可接受的载体,稀释剂和/或赋形剂组合。 所述药物组合物可用于治疗脑炎,如恶性疟原虫引起的脑疟疾。 因此,在另一方面,提供了用于治疗病原体的方法,例如诱导或引起的脑疾病,疾病或病症,包括脑炎,特别是脑疟疾的寄生原生动物,包括施用CB 2 R受体拮抗剂的步骤。